The 17th International Conference on Antiviral Research.
Identifieur interne : 005038 ( Main/Exploration ); précédent : 005037; suivant : 005039The 17th International Conference on Antiviral Research.
Auteurs : Robert W. Buckheit [États-Unis]Source :
- Expert opinion on investigational drugs [ 1744-7658 ] ; 2004.
Descripteurs français
- KwdFr :
- Animaux, Antiviraux (usage thérapeutique), Hepacivirus (), Herpesviridae (), Humains, Hépatite B (traitement médicamenteux), Hépatite C (traitement médicamenteux), Infections à Herpesviridae (traitement médicamenteux), Infections à VIH (traitement médicamenteux), Recherche (tendances), Syndrome respiratoire aigu sévère (traitement médicamenteux), Virus de l'hépatite B (), Virus du SRAS ().
- MESH :
- tendances : Recherche.
- traitement médicamenteux : Hépatite B, Hépatite C, Infections à Herpesviridae, Infections à VIH, Syndrome respiratoire aigu sévère.
- usage thérapeutique : Antiviraux.
- Animaux, Hepacivirus, Herpesviridae, Humains, Virus de l'hépatite B, Virus du SRAS.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (therapeutic use), HIV Infections (drug therapy), Hepacivirus (drug effects), Hepatitis B (drug therapy), Hepatitis B virus (drug effects), Hepatitis C (drug therapy), Herpesviridae (drug effects), Herpesviridae Infections (drug therapy), Humans, Research (trends), SARS Virus (drug effects), Severe Acute Respiratory Syndrome (drug therapy).
- MESH :
- chemical , therapeutic use : Antiviral Agents.
- drug effects : Hepacivirus, Hepatitis B virus, Herpesviridae, SARS Virus.
- drug therapy : HIV Infections, Hepatitis B, Hepatitis C, Herpesviridae Infections, Severe Acute Respiratory Syndrome.
- trends : Research.
- Animals, Humans.
Abstract
The focus of the 17th International Conference on Antiviral Research was the discovery and development of antiviral agents (chemistry, biology, animal models and clinical trial results) against a variety of human infectious agents including HIV, herpes viruses, hepatitis viruses, respiratory viruses and emerging/re-emerging pathogens. The meeting included the symposium 'Clinical Update on Antiviral Drugs', plenary sessions dedicated to each of the individual classes of infectious agents, a symposium on new developments surrounding emerging pathogens, and three special award lectures, which discussed the history of nucleotide antiviral agents, mechanisms of viral persistence and drug resistance, and the therapy of herpes virus infections. Within each infectious agent session the presentations included those describing the development of new and novel anti-infectives, including research based on the preclinical development of new molecules, and the results of animal modelling and clinical studies on advanced-stage antiviral agents. A summary of the meeting highlights, segregated by infectious agent, will be presented in this review.
DOI: 10.1517/13543784.13.9.1207
PubMed: 15330752
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002B99
- to stream PubMed, to step Curation: 002B99
- to stream PubMed, to step Checkpoint: 002996
- to stream Ncbi, to step Merge: 000A25
- to stream Ncbi, to step Curation: 000A25
- to stream Ncbi, to step Checkpoint: 000A25
- to stream Main, to step Merge: 005402
- to stream Main, to step Curation: 005038
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The 17th International Conference on Antiviral Research.</title><author><name sortKey="Buckheit, Robert W" sort="Buckheit, Robert W" uniqKey="Buckheit R" first="Robert W" last="Buckheit">Robert W. Buckheit</name><affiliation wicri:level="1"><nlm:affiliation>ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, Maryland 21704, USA. rbuckheit@imquest.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, Maryland 21704</wicri:regionArea><wicri:noRegion>Maryland 21704</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15330752</idno><idno type="pmid">15330752</idno><idno type="doi">10.1517/13543784.13.9.1207</idno><idno type="wicri:Area/PubMed/Corpus">002B99</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B99</idno><idno type="wicri:Area/PubMed/Curation">002B99</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B99</idno><idno type="wicri:Area/PubMed/Checkpoint">002996</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002996</idno><idno type="wicri:Area/Ncbi/Merge">000A25</idno><idno type="wicri:Area/Ncbi/Curation">000A25</idno><idno type="wicri:Area/Ncbi/Checkpoint">000A25</idno><idno type="wicri:Area/Main/Merge">005402</idno><idno type="wicri:Area/Main/Curation">005038</idno><idno type="wicri:Area/Main/Exploration">005038</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The 17th International Conference on Antiviral Research.</title><author><name sortKey="Buckheit, Robert W" sort="Buckheit, Robert W" uniqKey="Buckheit R" first="Robert W" last="Buckheit">Robert W. Buckheit</name><affiliation wicri:level="1"><nlm:affiliation>ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, Maryland 21704, USA. rbuckheit@imquest.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, Maryland 21704</wicri:regionArea><wicri:noRegion>Maryland 21704</wicri:noRegion></affiliation></author></analytic><series><title level="j">Expert opinion on investigational drugs</title><idno type="eISSN">1744-7658</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antiviral Agents (therapeutic use)</term><term>HIV Infections (drug therapy)</term><term>Hepacivirus (drug effects)</term><term>Hepatitis B (drug therapy)</term><term>Hepatitis B virus (drug effects)</term><term>Hepatitis C (drug therapy)</term><term>Herpesviridae (drug effects)</term><term>Herpesviridae Infections (drug therapy)</term><term>Humans</term><term>Research (trends)</term><term>SARS Virus (drug effects)</term><term>Severe Acute Respiratory Syndrome (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antiviraux (usage thérapeutique)</term><term>Hepacivirus ()</term><term>Herpesviridae ()</term><term>Humains</term><term>Hépatite B (traitement médicamenteux)</term><term>Hépatite C (traitement médicamenteux)</term><term>Infections à Herpesviridae (traitement médicamenteux)</term><term>Infections à VIH (traitement médicamenteux)</term><term>Recherche (tendances)</term><term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term><term>Virus de l'hépatite B ()</term><term>Virus du SRAS ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Hepacivirus</term><term>Hepatitis B virus</term><term>Herpesviridae</term><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term><term>Hepatitis C</term><term>Herpesviridae Infections</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Recherche</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Hépatite B</term><term>Hépatite C</term><term>Infections à Herpesviridae</term><term>Infections à VIH</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Research</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Hepacivirus</term><term>Herpesviridae</term><term>Humains</term><term>Virus de l'hépatite B</term><term>Virus du SRAS</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The focus of the 17th International Conference on Antiviral Research was the discovery and development of antiviral agents (chemistry, biology, animal models and clinical trial results) against a variety of human infectious agents including HIV, herpes viruses, hepatitis viruses, respiratory viruses and emerging/re-emerging pathogens. The meeting included the symposium 'Clinical Update on Antiviral Drugs', plenary sessions dedicated to each of the individual classes of infectious agents, a symposium on new developments surrounding emerging pathogens, and three special award lectures, which discussed the history of nucleotide antiviral agents, mechanisms of viral persistence and drug resistance, and the therapy of herpes virus infections. Within each infectious agent session the presentations included those describing the development of new and novel anti-infectives, including research based on the preclinical development of new molecules, and the results of animal modelling and clinical studies on advanced-stage antiviral agents. A summary of the meeting highlights, segregated by infectious agent, will be presented in this review.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Buckheit, Robert W" sort="Buckheit, Robert W" uniqKey="Buckheit R" first="Robert W" last="Buckheit">Robert W. Buckheit</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005038 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005038 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15330752
|texte= The 17th International Conference on Antiviral Research.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15330752" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |